Nutaria

Company Overview

Snapshot

Founded in June 2018, Nutaria operates with 1–10 employees and has secured $300,000 in total capital across one funding round. The company is currently in advanced preclinical stages, developing a drug specifically for early Parkinson's disease.

Business overview

Nutaria is a nutraceutical R&D company focused on revolutionizing drug delivery for brain health. The company utilizes a patented targeted delivery system that employs food molecules as natural carriers to deliver active ingredients directly to specific tissues or organs, enhancing the internalization and effectiveness of therapeutic agents. This technology, composed of FDA and EFSA-approved food ingredients, aims to improve the lives of individuals with neurodegenerative conditions, particularly through early treatment and prevention. Nutaria operates within the Health Tech & Life Sciences sector, with a focus on Pharma & Medical Biotechnology and Drug Delivery, serving patients and providers in markets such as North America, Europe, Japan, and Canada.

Company Intelligence Q&A

What is Nutaria's primary focus in drug development?

Nutaria is currently in advanced preclinical stages, developing a drug specifically for early Parkinson's disease, utilizing its patented targeted delivery system.

What is Nutaria's core technology for drug delivery?

Nutaria's core technology involves a patented targeted delivery system that uses food molecules as natural 'taxis' to deliver active ingredients directly to specific tissues or organs, improving absorption and effectiveness.

When was Nutaria founded?

Nutaria was founded in June 2018.

What is the current employee count for Nutaria?

Nutaria currently has 1–10 employees.

What is the total capital raised by Nutaria?

Nutaria has raised $300,000 in total capital.